Michel Delaage
Keine laufenden Positionen mehr
Karriereverlauf von Michel Delaage
Ehemalige bekannte Positionen von Michel Delaage
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Académie des Technologies
 Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | Corporate Officer/Principal | 18.11.2009 | - |
| IMMUNOTECH LABORATORIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.11.2009 | - |
| Gründer | 10.11.2009 | - | |
| TXCELL | Direktor/Vorstandsmitglied | 18.11.2009 | 17.02.2011 |
| Corporate Officer/Principal | 17.02.2011 | - | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Direktor/Vorstandsmitglied | 10.11.2009 | 17.02.2011 |
| Gründer | 21.12.1998 | - | |
| Corporate Officer/Principal | 17.02.2011 | - |
Ausbildung von Michel Delaage
| Ecole Polytechnique | Undergraduate Degree |
Statistik
International
| Frankreich | 5 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOTECH LABORATORIES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Académie des Technologies
Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. |
- Börse
- Insiders
- Michel Delaage
- Erfahrung
